FEED$0.3499+39.98%
ENvue Medical, Inc.
Sector: Orthopedic, Prosthetic & Surgical Appliances & SuppliesIndustry: Medical - SpecialtiesCountry: USExchange: OTC
Mkt Cap:$323.2K
Float & O/S:
Inst Own:
DilutionScan read 38 of ENvue Medical, Inc.'s SEC filings and found 8 warrant series, 4 convertibles, 1 equity line, 5 shelf registrations, 1 S-1 registration and 4 completed offerings on file for FEED. The latest dilution event on file is a registration statement on Sep 3, 2026. Analysis updated Oct 14, 2026.
Signal8 Summary
FEED
Going-concern warning from auditors
Snapshot
FEED is a deeply distressed medical-device micro-cap with a collapsed gross margin. FY 2025 revenue was flat at $2.6M, but gross profit fell 90% year-over-year to just $153K, a 6% margin that signals broken unit economics.
What's Happening Right Now
- : The company is soliciting stockholder approval for a reverse stock split ranging from 1-for-2 to 1-for-50 to regain compliance with Nasdaq listing rules, which would be its third reverse split in approximately 18 months.
- : Nasdaq notified ENvue Medical it is not in compliance with the minimum bid price requirement because its stock has closed below $1.00 for 30 consecutive business days, and the company is ineligible for the standard 180-day cure period due to a recent reverse split.
- : ENvue Medical filed a prospectus registering the resale of 6,000,768 shares of common stock by selling stockholder Alpha Capital Anstalt, representing approximately 53.4% dilution to existing shareholders.
- : The company reported a first quarter 2026 net loss of $3.8 million driven by a 36% decline in revenue, and auditors raised substantial doubt about its ability to continue as a going concern due to insufficient cash reserves.
